SNY (SNY) Stock Price & Analysis
SNY (SNY) fell 0.20% to USD 44.24 as of September 8, 2026 at 04:19 UTC, according to Nexqual real-time market data.
SNY last closed at USD 44.24; the session ranged USD 44.03–44.36 on volume of 1,695,047 shares. Market capitalization is —, with a 52-week range of USD 40.89–52.68 (NMS). Source: Nexqual, September 8, 2026 at 04:19 UTC.
Key Statistics (as of September 8, 2026 at 04:19 UTC)
| Price | USD 44.24 |
|---|---|
| Change | ▼ 0.20% (down) |
| Previous Close | USD 44.24 |
| Open | USD 44.24 |
| Day Range | USD 44.03 – 44.36 |
| 52-Week Range | USD 40.89 – 52.68 |
| Volume | 1,695,047 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (SNY)
Nexqual's technical model rates SNY "BUY" based on 4 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 04:19 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 47.25 (neutral) |
| vs SMA50 | Above (USD 43.91) |
| MACD | 0.18 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GSK | GSK plc | USD 49.89 | ▼ 1.09% |
| NVS | Novartis AG | USD 159.99 | ▼ 1.52% |
| AZN | AstraZeneca PLC | USD 162.7 | ▲ 0.66% |
| RHHBY | Roche Holding Ltd | USD 54.97 | ▲ 2.12% |
| REGN | Regeneron Pharmaceuticals, Inc. | USD 827.72 | ▼ 2.85% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:19 UTC. This page is informational and not investment advice.